GLDC mitigated by miR-30e regulates cell proliferation and tumor immune infiltration in TNBC

GLDC mitigated by miR-30e regulates cell proliferation and tumor immune infiltration in TNBC

BackgroundTNBC, whose clinical prognosis is poorer than other subgroups of breast cancer, is a malignant tumor characterized by lack of estrogen receptors, progesterone hormone receptors, and HER2 overexpression. Due to the lack of specific targeted drugs, it is crucial to identify critical factors...

Full description

Bibliographic Details
Main Authors: Huaying Xie, Tingting Yan, Xinxin Lu, Yueyao Du, Shuguang Xu, Yu Kong, Liangjie Yu, Jian Sun, Liheng Zhou, Jun Ma
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Immunology
Subjects:
TNBC
GLDC
proliferation
miR-30e
tumor immune
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1033367/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1033367/full

Similar Items